Financial Implications of Prostate Magnetic Resonance Imaging Without Contrast
Urol Pract
.
2024 Nov;11(6):915-917.
doi: 10.1097/UPJ.0000000000000646.
Epub 2024 Jun 21.
Authors
Benjamin Pockros
1
,
Matthew Davenport
1
2
,
Mitchell Mead
3
,
Ruchika Talwar
4
,
Samuel Kaffenberger
1
,
Rishi Sekar
1
,
Andrew Ibrahim
5
,
Todd M Morgan
1
Affiliations
1
Department of Urology, University of Michigan, Ann Arbor, Michigan.
2
Department of Radiology, University of Michigan, Ann Arbor, Michigan.
3
School of Medicine, University of Michigan, Ann Arbor, Michigan.
4
Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
5
Department of Surgery, University of Michigan, Ann Arbor, Michigan.
PMID:
39196665
DOI:
10.1097/UPJ.0000000000000646
No abstract available
Keywords:
MRI; access to care; active surveillance; financial toxicity; prostate cancer.